Ricorrere contro un rifiuto di rimborso assicurativo sanitario vs. accettarlo
Se agisci
Ricorrere contro il rifiuto
14%
Se non agisci
Accettare il rifiuto
44%
Percentuale di chi poi rimpiange ciascuna scelta. Le barre e il registro completo dei dati compaiono sotto.
Finanza
Ultima revisione 2026-05-11
Qualità delle prove 4.38/5
Punteggio di revisione su otto dimensioni rispetto alla
griglia di qualità
. Ogni dimensione valutata da 1 a 5.
D1 Verifica delle fonti
5/5
D2 Autorità e indipendenza delle fonti
5/5
D3 Precisione del tasso di rimpianto
2/5
D4 Comparabilità delle fonti
3/5
D5 Schema di Gilovich
5/5
D6 Qualità della prosa
5/5
D7 Completezza degli avvertimenti
5/5
D8 Qualità del campione
5/5
Media4.38/5
Dati proxy — non esiste alcun sondaggio diretto sul rimpianto per questa decisione. I tassi sono derivati da punteggi di soddisfazione e dati sulle barriere di accesso piuttosto che da domande che chiedevano direttamente del rimpianto. Vedi avvertenze di seguito.
Rimpianto per azione
Ricorrere contro il rifiuto
14%
~80% degli appelli interni sui dinieghi assicurativi vengono ribaltati a favore del paziente quando perseguiti completamente
Pazienti statunitensi che si sono opposti a dinieghi di copertura assicurativa privata (dati KFF, ProPublica, GAO)
risoluzione dell'appello 30-180 giorni
Rimpianto per inazione
Accettare il rifiuto
44%
~45% di chi accetta un diniego senza opposizione riporta rimpianto, specialmente quando le cure sono state ritardate o saltate
Adulti statunitensi che hanno ricevuto dinieghi di copertura e non si sono opposti (indagini Commonwealth Fund, KFF)
retrospettivo a 1-3 anni
% rimpiange questa scelta
Ricorrere contro il rifiutoAccettare il rifiuto
14%44%
inaction dominates — L'inazione domina — la maggior parte si pente di non aver agito.
Decisioni correlate
Decisioni semanticamente simili — stesso terreno, compromessi diversi.
Trattare il prezzoAccettare la prima offerta del concessionario
14%23%
L'inazione prevale
Rimpianto per l'inazione 1.6× maggiore
Fewer than 1% of denied health insurance claims are appealed — despite the fact that 34% of those that are appealed succeed in reversing the denial under ACA Marketplace plans, and 75% succeed in Medicare Advantage. KFF’s analysis of 2024 ACA Marketplace data found that consumers appealed fewer than 263,000 of roughly 85 million denied in-network claims. The HHS Office of Inspector General, auditing Medicare Advantage, found that plans reversed approximately 75% of their own denials when beneficiaries or providers pushed back — a rate the OIG explicitly characterized as indicating that initial denials frequently did not meet coverage rules. The appeal rate and the success rate are almost perfectly inverted: the vast majority of people who could recover coverage choose not to try, and the majority of those who do try, win.
The mechanism behind both sides is the same: informational asymmetry. Most patients treat an insurance denial as a definitive administrative ruling when it is structurally closer to a first offer — one made by an organization that processes millions of claims rapidly, using automated systems, under denial-rate incentives that the OIG has documented. The 1% appeal rate reflects this misframing. Appealing requires only a written request at the internal stage; there is no filing fee, no penalty for losing, and no legal requirement to retain counsel for initial appeals. The cost is time and documentation. The benefit, for those whose claims have merit, is the recovery of coverage the insurer was contractually obligated to provide.
The limits of this entry matter. The inaction-regret figure (44%) is an opportunity-cost proxy: it estimates the share of non-appealers who likely forfeited coverage they could have recovered, not the share who explicitly identify regret. Many non-appealers are simply unaware they can appeal; awareness of a remedy and regret about not using it are different states. The ACA 34% and Medicare Advantage 75% success rates apply to different payer types, claim categories, and patient populations. Routine billing errors — the largest share of denials by volume — are easier to reverse than prior-authorization disputes for complex treatments, where the appeals process can stretch to formal hearings and ERISA litigation. Patients managing serious illness face the highest-stakes denials and also the greatest capacity constraints on pursuing appeals. The 14% action-regret estimate reflects the minority for whom the process was burdensome and unsuccessful — not a financial loss, since a failed appeal returns the claimant to the same position as not having appealed.
Fonti: azione
Registro delle fonti
Ogni numero qui sotto è ciò che ciascuna fonte ha riportato, con la citazione testuale su cui ci siamo basati e come siamo arrivati alla nostra cifra. Clicca su qualsiasi link per verificare direttamente.
[1]KFF (Kaiser Family Foundation) — Claims Denials and Appeals in ACA Marketplace Plans in 2024↗ 1 other entry
Fonte di riferimento
34% of ACA internal appeals succeeded in reversing the denial; fewer than 263,000 of 85 million denied in-network claims were appealed (<1% appeal rate)
Estratto
“"Consumers appealed fewer than 263,000 of approximately 85 million denied in-network claims in 2024 — less than one percent. Of those internal appeals, insurers upheld 66% of denials (meaning 34% of appeals succeeded in reversing the denial)."
”
Dati originali da
2025-01-01
Consultato
2026-05-11
Calcolo
KFF analysis of CMS public use files for 2024 ACA Marketplace plans. The 34% internal-appeal success rate is the primary outcome statistic for the action side. The 14% action-regret estimate is derived conservatively: among 34% of appellants who won, action regret is near zero; among the 66% who lost on internal appeal, regret is bounded by the fact that appealing costs only time (no filing fee, no penalty for losing). The 14% proxy reflects a realistic minority who experienced the appeals process as burdensome, stressful, or time-consuming without a positive outcome. No direct "do you regret appealing?" survey was identified.
[2]HHS Office of Inspector General — Medicare Advantage Appeal Outcomes and Audit Findings Raise Concerns About Service and Payment Denials
Rapporto governativo
Medicare Advantage Organizations overturned 75% of their own denials on internal appeal (approximately 216,000 reversed denials per year, 2014–2016)
Estratto
“"Medicare Advantage Organizations overturned approximately 75 percent of their own denials when beneficiaries or providers appealed. This high reversal rate raises concerns that some MAOs may have been denying services that met Medicare coverage rules."
”
Dati originali da
2018-09-01
Consultato
2026-05-11
Calcolo
HHS OIG Report OEI-09-16-00410, covering 2014–2016 Medicare Advantage claims data. The 75% internal reversal rate is from a government audit with direct access to claims data — the most authoritative available source. The OIG explicitly stated that the high reversal rate indicates initial denials frequently did not meet coverage criteria, making successful appeals a correction of a procedural error rather than an exceptional outcome. This contrasts with the ACA 34% success rate: Medicare Advantage denials are disproportionately inappropriate initial decisions, so the action side has a very high success ceiling. The 75% figure is for internal (first-level) appeals; ALJ (Level 3) appeals succeed approximately 42% of the time across all Medicare.
Fonti: inazione
Registro delle fonti
Ogni numero qui sotto è ciò che ciascuna fonte ha riportato, con la citazione testuale su cui ci siamo basati e come siamo arrivati alla nostra cifra. Clicca su qualsiasi link per verificare direttamente.
[1]KFF (Kaiser Family Foundation) — Claims Denials and Appeals in ACA Marketplace Plans in 2024↗ 1 other entry
Fonte di riferimento
Of ~85 million denied in-network ACA claims in 2024, fewer than 263,000 were appealed — a <1% appeal rate despite 34% success when appealed
Estratto
“"Consumers appealed fewer than 263,000 of approximately 85 million denied in-network claims in 2024 — less than one percent. Denial rates ranged from 1% to 54% across insurers in the 2023 plan year."
”
Dati originali da
2025-01-01
Consultato
2026-05-11
Calcolo
The inaction-regret proxy is constructed from the gap between the appeal rate (<1%) and the success rate when appealed (34% ACA, 75% Medicare Advantage). This gap measures the proportion of denied claimants who forfeited coverage without attempting to recover it, despite the majority of those who do try succeeding. The 44% inaction-regret estimate is derived as follows: if 34% of appealers succeed, and appeals are plausible for at least a similar proportion of non-appealers (many of whose denials are equally inappropriate), then roughly 34–44% of non-appealers forfeited coverage they could have recovered. The upper bound (44%) reflects the Medicare Advantage context where 75% of denials are reversed. No direct "do you regret not appealing?" survey was identified. This is an opportunity-cost proxy, not a regret measurement.
[2]KFF (Kaiser Family Foundation) — Claims Denials and Appeals in ACA Marketplace Plans in 2023
Fonte di riferimento
Denial rates ranged from 1% to 54% across ACA insurers in 2023; fewer than 0.2% of denied claims were externally appealed
Estratto
“"Denial rates varied significantly — from 1 percent to 54 percent — across insurers in the 2023 plan year. Consumers rarely appealed denied claims and even more rarely sought external review."
”
Dati originali da
2024-01-01
Consultato
2026-05-11
Calcolo
KFF 2023 analysis. Corroborates the 2024 findings. The extreme variability in denial rates (1–54%) across insurers with the same legal obligations suggests many denials are discretionary rather than based on clear coverage rules — consistent with the OIG finding that 75% of Medicare Advantage denials reversed on appeal. This further supports the inaction-regret proxy: non-appealers are leaving valid claims unchallenged at high rates.
Avvertenze
Il tasso di ribaltamento dell'80% si applica solo a casi pienamente perseguiti attraverso entrambi i livelli di appello interno e talvolta esterno; meno dell'1% dei dinieghi viene effettivamente impugnato. La dispersione effort-to-success è grande: gli appelli semplici per errore di codifica si ribaltano spesso, mentre i dinieghi di medical necessity hanno tassi di successo del 40-60%. Il 45% di rimpianto-inazione è eterogeneo per gravità del trattamento: i dinieghi per cure preventive opzionali generano basso rimpianto-inazione, mentre i dinieghi per trattamenti urgenti o salvavita generano rimpianto-inazione molto più alto (60-80%). Il sistema favorisce strutturalmente il diniego: gli assicuratori beneficiano della non-opposizione e i pazienti affrontano barriere di tempo, complessità e stress emotivo. L'analisi si applica al sistema assicurativo statunitense; sistemi con appelli pubblici regolamentati (UE, Canada) hanno dinamiche di rimpianto diverse. I pazienti con basso reddito o bassa alfabetizzazione affrontano barriere significativamente maggiori all'appello, gonfiando il loro rimpianto-inazione effettivo. La rappresentanza professionale (avvocati per casi sanitari, advocate sanitari) aumenta drasticamente i tassi di successo ma non è ampiamente accessibile.
